26.10
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Stoke Therapeutics Inc Borsa (STOK) Ultime notizie
Stoke Therapeutics (STOK): JP Morgan Raises Price Target, Mainta - GuruFocus
Live market analysis of Stoke Therapeutics Inc.Buy Signal & Stock Portfolio Risk Management - newser.com
Why Stoke Therapeutics Inc. stock attracts high net worth investorsQuarterly Growth Report & Free Expert Verified Stock Movement Alerts - newser.com
Can Stoke Therapeutics Inc. stock sustain institutional interestMarket Activity Summary & Daily Momentum Trading Reports - newser.com
Using portfolio simulators with Stoke Therapeutics Inc. includedJuly 2025 Institutional & Safe Capital Investment Plans - newser.com
What technical models suggest about Stoke Therapeutics Inc.’s comebackJuly 2025 Highlights & Risk Managed Investment Strategies - newser.com
What insider trading reveals about Stoke Therapeutics Inc. stockJuly 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - newser.com
Will Stoke Therapeutics Inc. stock maintain momentum in 2025Market Sentiment Summary & Fast Exit/Entry Strategy Plans - newser.com
Does Stoke Therapeutics Inc. show high probability of rebound2025 Trading Volume Trends & Community Trade Idea Sharing - newser.com
Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Stoke Therapeutics Shares Plunge Following Clinical Trial Data Release - AD HOC NEWS
Stoke Therapeutics (NASDAQ:STOK) Stock Price Down 6.3%Should You Sell? - MarketBeat
Is Stoke Therapeutics Inc. stock a good choice for value investorsTrade Entry Report & Short-Term Trading Opportunity Alerts - newser.com
Stoke Therapeutics Inc expected to post a loss of 57 cents a shareEarnings Preview - TradingView
Exit strategy if you’re trapped in Stoke Therapeutics Inc.July 2025 Macro Moves & Weekly High Return Opportunities - newser.com
Stoke Therapeutics, Inc. (STOK) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Total debt per share of Stoke Therapeutics, Inc. – BER:0GT - TradingView
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2025 Business and Financial Updates - Yahoo Finance
Stoke Therapeutics (STOK) Price Target Increased by 16.51% to 28.79 - Nasdaq
Stoke Therapeutics (STOK) Projected to Post Earnings on Tuesday - MarketBeat
Will Stoke Therapeutics Inc. stock maintain dividend yieldExit Point & AI Forecast for Swing Trade Picks - Fundação Cultural do Pará
Why Stoke Therapeutics Inc. stock is popular among millennialsTrade Performance Summary & Stock Market Timing Techniques - fcp.pa.gov.br
Take Profit: Is Stoke Therapeutics Inc. stock a good choice for value investorsTrade Risk Summary & Target Return Focused Stock Picks - fcp.pa.gov.br
Dravet Syndrome Pipeline 2025: Key Developments, Emerging - openPR.com
How Stoke Therapeutics Inc. stock trades before earningsDividend Hike & Step-by-Step Swing Trade Plans - Fundação Cultural do Pará
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):